These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33844277)

  • 1. Antibody disulfide bond reduction and recovery during biopharmaceutical process development-A review.
    Ren T; Tan Z; Ehamparanathan V; Lewandowski A; Ghose S; Li ZJ
    Biotechnol Bioeng; 2021 Aug; 118(8):2829-2844. PubMed ID: 33844277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and kinetic modeling of interchain disulfide bond reoxidation of monoclonal antibodies in bioprocesses.
    Tang P; Tan Z; Ehamparanathan V; Ren T; Hoffman L; Du C; Song Y; Tao L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829336. PubMed ID: 33031716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process.
    Du C; Huang Y; Borwankar A; Tan Z; Cura A; Yee JC; Singh N; Ludwig R; Borys M; Ghose S; Mussa N; Li ZJ
    MAbs; 2018 Apr; 10(3):500-510. PubMed ID: 29336721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-column disulfide bond formation of monoclonal antibodies during Protein A chromatography eliminates low molecular weight species and rescues reduced antibodies.
    Tan Z; Ehamparanathan V; Ren T; Tang P; Hoffman L; Kuang J; Liu P; Huang C; Du C; Tao L; Chemmalil L; Lewandowski A; Ghose S; Li ZJ; Liu S
    MAbs; 2020; 12(1):1829333. PubMed ID: 33016217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione and thioredoxin systems contribute to recombinant monoclonal antibody interchain disulfide bond reduction during bioprocessing.
    Handlogten MW; Zhu M; Ahuja S
    Biotechnol Bioeng; 2017 Jul; 114(7):1469-1477. PubMed ID: 28262915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of depth filtration on disulfide bond reduction during downstream processing of monoclonal antibodies from CHO cell cultures.
    O'Mara B; Gao ZH; Kuruganti M; Mallett R; Nayar G; Smith L; Meyer JD; Therriault J; Miller C; Cisney J; Fann J
    Biotechnol Bioeng; 2019 Jul; 116(7):1669-1683. PubMed ID: 30883673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing.
    Trexler-Schmidt M; Sargis S; Chiu J; Sze-Khoo S; Mun M; Kao YH; Laird MW
    Biotechnol Bioeng; 2010 Jun; 106(3):452-61. PubMed ID: 20178122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent mass spectrometry-based techniques and considerations for disulfide bond characterization in proteins.
    Lakbub JC; Shipman JT; Desaire H
    Anal Bioanal Chem; 2018 Apr; 410(10):2467-2484. PubMed ID: 29256076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability.
    Chung WK; Russell B; Yang Y; Handlogten M; Hudak S; Cao M; Wang J; Robbins D; Ahuja S; Zhu M
    Biotechnol Bioeng; 2017 Jun; 114(6):1264-1274. PubMed ID: 28186329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.
    Hutterer KM; Hong RW; Lull J; Zhao X; Wang T; Pei R; Le ME; Borisov O; Piper R; Liu YD; Petty K; Apostol I; Flynn GC
    MAbs; 2013; 5(4):608-13. PubMed ID: 23751615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives.
    Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ
    Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Online control of cell culture redox potential prevents antibody interchain disulfide bond reduction.
    Handlogten MW; Wang J; Ahuja S
    Biotechnol Bioeng; 2020 May; 117(5):1329-1336. PubMed ID: 31956991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation.
    Swope N; Chung WK; Cao M; Motabar D; Liu D; Ahuja S; Handlogten M
    Biotechnol Bioeng; 2020 Apr; 117(4):1063-1071. PubMed ID: 31930476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted proteomics reveals upregulation of stress response pathways during CHO-based monoclonal antibody manufacturing process leading to disulfide bond reduction.
    Park SY; Egan S; Cura AJ; Aron KL; Xu X; Zheng M; Borys M; Ghose S; Li Z; Lee K
    MAbs; 2021; 13(1):1963094. PubMed ID: 34424810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
    Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
    MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of antibody disulfide reduction and re-oxidation and impact to biological activities.
    Wang T; Liu YD; Cai B; Huang G; Flynn GC
    J Pharm Biomed Anal; 2015 Jan; 102():519-28. PubMed ID: 25459952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of disulfide and hinge modifications in monoclonal antibodies.
    Moritz B; Stracke JO
    Electrophoresis; 2017 Mar; 38(6):769-785. PubMed ID: 27982442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Identification of Disulfide Bonds and Cysteine-Related Variants in an IgG1 Knob-into-Hole Bispecific Antibody Enhanced by Machine Learning.
    Baker JJ; McDaniel D; Cain D; Lee Tao P; Li C; Huang Y; Liu H; Zhu-Shimoni J; Niñonuevo M
    Anal Chem; 2019 Jan; 91(1):965-976. PubMed ID: 30501176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine in cell culture media induces acidic IgG1 species by disrupting the disulfide bond network.
    Prade E; Zeck A; Stiefel F; Unsoeld A; Mentrup D; Arango Gutierrez E; Gorr IH
    Biotechnol Bioeng; 2021 Mar; 118(3):1091-1104. PubMed ID: 33200817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.